Seikagaku competitive analysis

Latest publications and patents of Seikagaku New

Explore the latest publications and patents granted to Seikagaku, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Seikagaku

Feb 28, 2024Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameGranted And Under Opposition
Feb 5, 2020Method For Producing A Novel Recombinant Factor C, Method For Mitigating Reaction Inhibition In Endotoxin Assays, And Method For Measuring EndotoxinRevoked
Jan 3, 2018Compositions And Methods For Bacterial Production Of ChondroitinNo Opposition Filed Within Time Limit

Explore Seikagaku's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 28, 2024Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding Same1
Feb 5, 2020Method For Producing A Novel Recombinant Factor C, Method For Mitigating Reaction Inhibition In Endotoxin Assays, And Method For Measuring Endotoxin1

Latest PTAB cases involving Seikagaku

Discover the latest PTAB cases involving Seikagaku, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 6, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Seikagaku

IPR2025-00440Jan 16, 2025CHARLES RIVER LABORATORIESSEIKAGAKUTrial Instituted
PGR2025-00023Jan 15, 2025CHARLES RIVER LABORATORIESSEIKAGAKUTrial Instituted

Peer Comparison New

IP litigation analysis comparing Seikagaku with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SEIKAGAKU - 2 - 2Non-Active
CHARLES RIVER LABORATORIES - - 5 - Highly Aggressive
POHLMAN30 - - - Highly Aggressive